BIB holdings

Holdings

as of Oct 21, 2026issuer data

#	Holding	Type	Weight	Value	Shares / par	Country
1	NASDAQ Biotechnology Index SWAP Bank of America NA	Derivative	36.27%	$35M	4,901
2	NASDAQ Biotechnology Index SWAP Citibank NA	Derivative	30.68%	$30M	4,145
3	NASDAQ Bio Index SWAP BNP Paribas	Derivative	29.33%	$28M	3,963
4	Net Other Assets (Liabilities)	Cash	21.37%	$21M	20,572,653
5	NASDAQ Biotechnology Index SWAP Goldman Sachs International	Derivative	19.53%	$19M	2,639
6	NASDAQ Biotechnology Index SWAP Societe Generale	Derivative	18.60%	$18M	2,513
7	IQMMProShares GENIUS Money Market ETF	Cash	17.67%	$17M	170,000
8	GILDGilead Sciences Inc	Equity	5.12%	$4.9M	32,070	US
9	AMGNAmgen Inc	Equity	4.97%	$4.8M	10,917	US
10	VRTXVertex Pharmaceuticals Inc	Equity	4.70%	$4.5M	8,619	US
11	NASDAQ Biotechnology Index SWAP UBS AG	Derivative	4.66%	$4.5M	629
12	MRNAModerna, Inc. Common Stock	Equity	3.92%	$3.8M	15,337	US
13	REGNRegeneron Pharmaceuticals Inc	Equity	3.25%	$3.1M	3,885	US
14	ILMNIllumina Inc	Equity	1.70%	$1.6M	5,801	US
15	RVMDRevolution Medicines, Inc. Common Stock	Equity	1.66%	$1.6M	8,234	US
16	BIIBBiogen Inc. Common Stock	Equity	1.42%	$1.4M	5,676	US
17	ALNYAlnylam Pharmaceuticals, Inc.	Equity	1.20%	$1.2M	5,140	US
18	RPRXRoyalty Pharma plc Class A Ordinary Shares	Equity	1.10%	$1.1M	17,106
19	ROIVRoivant Sciences Ltd. Common Shares	Equity	1.06%	$1.0M	27,749	US
20	ARGXargenx SE American Depositary Shares	Equity	0.97%	$933K	1,048
21	UTHRUnited Therapeutics Corp	Equity	0.96%	$929K	1,648	US
22	INCYIncyte Genomics Inc	Equity	0.92%	$883K	7,787	US
23	GHGuardant Health, Inc. Common Stock	Equity	0.89%	$859K	5,155	US
24	VTRSViatris Inc. Common Stock	Equity	0.85%	$814K	44,124	US
25	INSMInsmed, Inc.	Equity	0.82%	$789K	8,389	US
26	MEDPMedpace Holdings, Inc. Common Stock	Equity	0.74%	$710K	1,072	US
27	EXELExelixis Inc	Equity	0.64%	$615K	9,519	US
28	ASNDAscendis Pharma A/S Ordinary Share	Equity	0.59%	$565K	2,365	DK
29	NBIXNeurocrine Biosciences Inc	Equity	0.57%	$552K	3,905	US
30	HALOHalozyme Therapeutics, Inc.	Equity	0.57%	$544K	4,360	US
31	ONCBeOne Medicines Ltd. American Depositary Shares	Equity	0.55%	$532K	1,377
32	JAZZJazz Pharmaceuticals, Inc.	Equity	0.55%	$529K	2,494
33	BBIOBridgeBio Pharma, Inc. Common Stock	Equity	0.54%	$522K	7,702	US
34	SMMTSummit Therapeutics Inc. Common Stock	Equity	0.50%	$485K	30,646	US
35	TEMTempus AI, Inc. Class A Common Stock	Equity	0.47%	$457K	6,738	US
36	BMRNBioMarin Pharmaceuticals Inc	Equity	0.43%	$411K	7,436	US
37	MDGLMadrigal Pharmaceuticals, Inc. Common Stock	Equity	0.42%	$407K	888	US
38	BNTXBioNTech SE American Depositary Share	Equity	0.42%	$406K	4,448	DE
39	TWSTTwist Bioscience Corporation Common Stock	Equity	0.39%	$380K	2,548	US
40	KRYSKrystal Biotech, Inc. Common Stock	Equity	0.38%	$366K	1,137	US
41	PCVXVaxcyte, Inc. Common Stock	Equity	0.38%	$361K	5,716	US
42	KYMRKymera Therapeutics, Inc. Common Stock	Equity	0.37%	$360K	3,194	US
43	IBRXImmunityBio, Inc. Common Stock	Equity	0.37%	$352K	40,715	US
44	CAICaris Life Sciences, Inc. Common Stock	Equity	0.36%	$351K	10,856	US
45	TXG10x Genomics, Inc. Class A Common Stock	Equity	0.36%	$349K	4,618	US
46	PTGXProtagonist Therapeutics, Inc	Equity	0.36%	$343K	2,486	US
47	SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	Equity	0.35%	$339K	8,282	FR
48	CYTKCytokinetics Inc.	Equity	0.35%	$336K	5,341	US
49	ARWRArrowhead Research Corporation	Equity	0.33%	$319K	5,426	US
50	SYRESpyre Therapeutics, Inc. Common Stock	Equity	0.33%	$315K	3,387	US
51	AXSMAxsome Therapeutics, Inc	Equity	0.33%	$314K	2,012	US
52	IONSIonis Pharmaceuticals, Inc. Common Stock	Equity	0.29%	$283K	6,384	US
53	ALKSAlkermes Inc. plc	Equity	0.29%	$280K	6,445
54	PRAXPraxis Precision Medicines, Inc. Common Stock	Equity	0.29%	$275K	1,073	US
55	AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	Equity	0.28%	$270K	13,380	US
56	IOVAIovance Biotherapeutics, Inc. Common Stock	Equity	0.26%	$254K	17,401	US
57	LGNDLigand Pharmaceuticals Inc.	Equity	0.25%	$241K	766	US
58	RYTMRhythm Pharmaceuticals, Inc. Common Stock	Equity	0.24%	$234K	2,645	US
59	GRALGRAIL, Inc. Common Stock	Equity	0.24%	$228K	1,716	US
60	IMVTImmunovant, Inc. Common Stock	Equity	0.23%	$225K	7,935	US
61	CGONCG Oncology, Inc. Common stock	Equity	0.22%	$212K	3,405	US
62	KODKodiak Sciences Inc Common Stock	Equity	0.22%	$212K	2,414	US
63	COGTCogent Biosciences, Inc. Common Stock	Equity	0.22%	$210K	6,666	US
64	MIRMMirum Pharmaceuticals, Inc. Common Stock	Equity	0.22%	$208K	2,494	US
65	ABVXAbivax SA American Depositary Shares	Equity	0.21%	$205K	2,196	FR
66	ORKAOruka Therapeutics, Inc. Common Stock	Equity	0.21%	$203K	2,544	US
67	SRRKScholar Rock Holding Corporation Common Stock	Equity	0.21%	$201K	4,678	US
68	PTCTPTC Therapeutics, Inc.	Equity	0.21%	$201K	3,206	US
69	ERASErasca, Inc. Common Stock	Equity	0.20%	$195K	13,436	US
70	TVTXTravere Therapeutics, Inc. Common Stock	Equity	0.20%	$190K	3,621	US
71	CRSPCRISPR Therapeutics AG	Equity	0.19%	$188K	3,715
72	DFTXDefinium Therapeutics, Inc. Common Shares	Equity	0.19%	$183K	5,162
73	TNGXTango Therapeutics, Inc.	Equity	0.18%	$175K	6,477	US
74	EWTXEdgewise Therapeutics, Inc. Common Stock	Equity	0.17%	$165K	4,172	US
75	INDVIndivior Pharmaceuticals, Inc. Common Stock	Equity	0.16%	$158K	4,534	US
76	ADPTAdaptive Biotechnologies Corporation Common Stock	Equity	0.16%	$155K	6,131	US
77	RLAYRelay Therapeutics, Inc. Common Stock	Equity	0.16%	$155K	8,419	US
78	ARQTArcutis Biotherapeutics, Inc. Common Stock	Equity	0.16%	$154K	4,829	US
79	ABCLAbCellera Biologics Inc. Common Shares	Equity	0.16%	$152K	12,449	CA
80	KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	Equity	0.15%	$148K	1,855	US
81	GMABGenmab A/S ADS	Equity	0.15%	$147K	3,725	DK
82	VCYTVeracyte, Inc.	Equity	0.15%	$143K	3,088	US
83	AMLXAmylyx Pharmaceuticals, Inc. Common Stock	Equity	0.15%	$140K	4,822	US
84	XENEXenon Pharmaceuticals Inc	Equity	0.14%	$134K	3,720
85	ACADAcadia Pharmaceuticals Inc.	Equity	0.14%	$134K	6,619	US
86	IDYAIDEAYA Biosciences, Inc. Common Stock	Equity	0.14%	$131K	3,707	US
87	TARSTarsus Pharmaceuticals, Inc. Common Stock	Equity	0.13%	$125K	1,766	US
88	ELVNEnliven Therapeutics, Inc. Common Stock	Equity	0.12%	$118K	2,815	US
89	DYNDyne Therapeutics, Inc. Common Stock	Equity	0.12%	$115K	7,174	US
90	DNLIDenali Therapeutics Inc. Common Stock	Equity	0.12%	$115K	6,141	US
91	IRONDisc Medicine, Inc. Common Stock	Equity	0.12%	$112K	1,475	US
92	NRIXNurix Therapeutics, Inc. Common stock	Equity	0.11%	$104K	3,987	US
93	MBXMBX Biosciences, Inc. Common Stock	Equity	0.10%	$100K	1,850	US
94	NEWAMSTERDAM PHARMA CO NV	Equity	0.10%	$99K	4,592
95	BEAMBeam Therapeutics Inc. Common Stock	Equity	0.10%	$99K	3,968	US
96	ADMAADMA Biologics, Inc.	Equity	0.10%	$95K	8,605	US
97	SUPNSupernus Pharmaceuticals, Inc.	Equity	0.10%	$92K	2,233	US
98	PGENPrecigen, Inc. Common Stock	Equity	0.09%	$91K	13,754	US
99	FTREFortrea Holdings Inc. Common Stock	Equity	0.09%	$88K	3,653	US
100	AUPHAurinia Pharmaceuticals Inc	Equity	0.09%	$86K	5,111
101	VERAVera Therapeutics, Inc. Class A Common Stock	Equity	0.09%	$86K	2,768	US
102	HRMYHarmony Biosciences Holdings, Inc. Common Stock	Equity	0.09%	$86K	2,237	US
103	AGIOAgios Pharmaceuticals, Inc.	Equity	0.09%	$85K	2,294	US
104	PHVSPharvaris N.V. Ordinary Shares	Equity	0.09%	$83K	2,697	NL
105	VCELVericel Corporation	Equity	0.08%	$81K	1,967	US
106	ZYMEZymeworks Inc.	Equity	0.08%	$77K	2,726	US
107	BCRXBioCryst Pharmaceuticals Inc	Equity	0.08%	$76K	9,817	US
108	XERSXeris Biopharma Holdings, Inc. Common Stock	Equity	0.08%	$76K	7,004	US
109	SRPTSarepta Therapeutics,, Inc. Common Stock	Equity	0.08%	$75K	4,058	US
110	RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	Equity	0.08%	$75K	20,566	US
111	SEPNSepterna, Inc. Common Stock	Equity	0.08%	$73K	1,793	US
112	XNCRXencor, Inc.	Equity	0.07%	$72K	2,856	US
113	MLYSMineralys Therapeutics, Inc. Common Stock	Equity	0.07%	$72K	3,396	US
114	ZBIOZenas BioPharma, Inc. Common Stock	Equity	0.07%	$70K	2,504	US
115	TRVITrevi Therapeutics, Inc. Common Stock	Equity	0.07%	$70K	5,473	US
116	NVAXNovavax Inc	Equity	0.07%	$70K	6,337	US
117	NVCRNovoCure Limited Ordinary Shares	Equity	0.07%	$70K	4,473
118	MAZEMaze Therapeutics, Inc. Common Stock	Equity	0.07%	$70K	2,134	US
119	GPCRStructure Therapeutics Inc. American Depositary Shares	Equity	0.07%	$69K	3,149
120	VIRVir Biotechnology, Inc. Common Stock	Equity	0.07%	$69K	6,501	US
121	ALVOAlvotech Ordinary Shares	Equity	0.07%	$67K	12,993
122	URGNUroGen Pharma Ltd. Ordinary Shares	Equity	0.07%	$67K	1,878	US
123	ABSIAbsci Corporation Common Stock	Equity	0.07%	$66K	6,593	US
124	LEGNLegend Biotech Corporation American Depositary Shares	Equity	0.07%	$66K	3,538
125	PSNLPersonalis, Inc. Common Stock	Equity	0.07%	$65K	4,103	US
126	ANIPANI Pharmaceuticals, Inc.	Equity	0.07%	$64K	882	US
127	STOKStoke Therapeutics, Inc. Common Stock	Equity	0.07%	$64K	2,479	US
128	NTLAIntellia Therapeutics, Inc	Equity	0.07%	$63K	5,383	US
129	CMPSCOMPASS Pathways Plc American Depository Shares	Equity	0.06%	$61K	5,144
130	QUREuniQure N.V.	Equity	0.06%	$60K	2,665
131	RAREUltragenyx Pharmaceutical Inc.	Equity	0.06%	$60K	3,787	US
132	TRAXFirst Tracks Biotherapeutics, Inc. Ordinary Shares	Equity	0.06%	$59K	1,373	US
133	INVAInnoviva, Inc. Common Stock	Equity	0.06%	$58K	2,775	US
134	IMCRImmunocore Holdings plc American Depositary Shares	Equity	0.06%	$57K	1,780	GB
135	PCRXPacira BioSciences, Inc. Common Stock	Equity	0.06%	$56K	1,531	US
136	INBXInhibrx Biosciences, Inc. Common Stock	Equity	0.06%	$55K	565	US
137	ORICOric Pharmaceuticals, Inc. Common Stock	Equity	0.06%	$55K	3,982	US
138	OCULOcular Therapeutix, Inc.	Equity	0.06%	$55K	8,437	US
139	ANABAnaptysBio, Inc. Common Stock	Equity	0.06%	$55K	1,137	US
140	ETONEton Pharmaceutcials, Inc. Common Stock	Equity	0.06%	$54K	1,098	US
141	TSHATaysha Gene Therapies, Inc. Common Stock	Equity	0.05%	$52K	12,517	US
142	GHRSGH Research PLC Ordinary Shares	Equity	0.05%	$50K	2,637	IE
143	TYRATyra Biosciences, Inc. Common Stock	Equity	0.05%	$47K	2,293	US
144	RAPPRapport Therapeutics, Inc. Common Stock	Equity	0.05%	$46K	1,843	US
145	BCAXBicara Therapeutics Inc. Common Stock	Equity	0.05%	$46K	2,542	US
146	OMEROmeros Corporation	Equity	0.05%	$45K	2,781	US
147	SNDXSyndax Pharmaceuticals, Inc.	Equity	0.05%	$45K	3,430	US
148	MRVIMaravai LifeSciences Holdings, Inc. Class A Common Stock	Equity	0.05%	$43K	5,724	US
149	VORVor Biopharma Inc. Common Stock	Equity	0.04%	$43K	2,273	US
150	AMPHAmphastar Pharmaceuticals, Inc.	Equity	0.04%	$43K	1,634	US
151	REPLReplimune Group, Inc.	Equity	0.04%	$42K	3,620	US
152	ZLABZai Lab Limited American Depositary Shares	Equity	0.04%	$41K	1,712
153	HROWHarrow, Inc. Common Stock	Equity	0.04%	$41K	1,440	US
154	CSTLCastle Biosciences, Inc. Common Stock	Equity	0.04%	$40K	1,174	US
155	JANXJanux Therapeutics, Inc. Common Stock	Equity	0.04%	$40K	2,349	US
156	MNKDMannkind Corporation	Equity	0.04%	$38K	12,352	US
157	SVRASavara Inc.	Equity	0.04%	$37K	7,893	US
158	CGEMCullinan Therapeutics, Inc. Common Stock	Equity	0.04%	$37K	2,472	US
159	GLUEMonte Rosa Therapeutics, Inc. Common Stock	Equity	0.04%	$37K	3,277	US
160	MGTXMeiraGTx Holdings plc Ordinary Shares	Equity	0.04%	$36K	3,690	US
161	AVBPArriVent BioPharma, Inc. Common Stock	Equity	0.04%	$36K	1,894	US
162	SLNSilence Therapeutics Plc American Depository Share	Equity	0.04%	$36K	1,805	GB
163	GRFSGrifois, S.A.	Equity	0.04%	$35K	4,687	ES
164	RIGLRigel Pharmaceuticals Inc. (New)	Equity	0.04%	$35K	718	US
165	ALMSAlumis Inc. Common Stock	Equity	0.04%	$34K	4,972	US
166	KURAKura Oncology, Inc.	Equity	0.04%	$34K	3,418	US
167	CRVSCorvus Pharmaceuticals, Inc.	Equity	0.03%	$32K	3,232	US
168	PAHCPhibro Animal Health Corporation Class A	Equity	0.03%	$32K	811	US
169	ABUSArbutus Biopharma Corporation Common Stock	Equity	0.03%	$32K	7,601
170	ARDXArdelyx, Inc.	Equity	0.03%	$30K	9,573	US
171	COLLCollegium Pharmaceutical, Inc. Common Stock	Equity	0.03%	$29K	1,251	US
172	GERNGeron Corp	Equity	0.03%	$29K	24,681	US
173	ANNXAnnexon, Inc. Common Stock	Equity	0.03%	$28K	7,283	US
174	OABIOmniAb, Inc. Common Stock	Equity	0.03%	$27K	5,585	US
175	SANASana Biotechnology, Inc. Common Stock	Equity	0.03%	$27K	11,500	US
176	FDMT4D Molecular Therapeutics, Inc. Common Stock	Equity	0.03%	$27K	2,122	US
177	PRMEPrime Medicine, Inc. Common Stock	Equity	0.03%	$27K	6,968	US
178	SLDBSolid Biosciences Inc. Common Stock	Equity	0.03%	$26K	4,119	US
179	MESOMesoblast Limited American Depositary Shares	Equity	0.03%	$26K	2,014	AU
180	DSGNDesign Therapeutics, Inc. Common Stock	Equity	0.03%	$26K	2,404	US
181	AURAAura Biosciences, Inc. Common Stock	Equity	0.03%	$26K	3,984	US
182	PACBPacific Biosciences of California, Inc.	Equity	0.03%	$26K	11,941	US
183	WVEWave Life Sciences Ltd. Ordinary Shares	Equity	0.03%	$26K	7,570	US
184	CADLCandel Therapeutics, Inc. Common Stock	Equity	0.03%	$25K	2,940	US
185	OLMAOlema Pharmaceuticals, Inc. Common Stock	Equity	0.02%	$24K	3,361	US
186	SGMTSagimet Biosciences Inc. Series A Common Stock	Equity	0.02%	$24K	2,366	US
187	ZVRAZevra Therapeutics, Inc. Common Stock	Equity	0.02%	$24K	2,281	US
188	CRMDCorMedix Inc.	Equity	0.02%	$23K	2,994	US
189	IRWDIronwood Pharmaceuticals, Inc. - Class A	Equity	0.02%	$23K	6,348	US
190	PHATPhathom Pharmaceuticals, Inc. Common Stock	Equity	0.02%	$22K	3,108	US
191	PBYIPUMA BIOTECHNOLOGY INC	Equity	0.02%	$22K	1,983	US
192	ACRSAclaris Therapeutics, Inc.	Equity	0.02%	$22K	5,655	US
193	CTMXCytomX Therapeutics, Inc.	Equity	0.02%	$20K	8,371	US
194	NGNENeurogene, Inc. Common Stock	Equity	0.02%	$20K	769	US
195	AQSTAquestive Therapeutics, Inc. Common Stock	Equity	0.02%	$20K	4,822	US
196	ARVNArvinas, Inc	Equity	0.02%	$19K	2,512	US
197	EOLSEvolus, Inc. Common Stock	Equity	0.02%	$19K	2,537	US
198	RGNXREGENXBIO Inc.	Equity	0.02%	$18K	2,536	US
199	ALLOAllogene Therapeutics, Inc. Common Stock	Equity	0.02%	$18K	13,272	US
200	LKFTLakefront Biotherapeutics American Depositary Shares	Equity	0.02%	$17K	572	BE
201	KMDAKamada Ltd	Equity	0.02%	$17K	2,216	IL
202	ALTAltimmune, Inc. Common Stock	Equity	0.02%	$17K	7,473	US
203	TECXTectonic Therapeutic, Inc. Common Stock	Equity	0.02%	$16K	751	US
204	SPRYARS Pharmaceuticals, Inc. Common Stock	Equity	0.02%	$16K	3,820	US
205	PRTAProthena Corporation plc Ordinary Shares	Equity	0.02%	$16K	1,972	US
206	CCCCC4 Therapeutics, Inc.	Equity	0.02%	$15K	4,726	US
207	EDITEditas Medicine, Inc. Common Stock	Equity	0.02%	$15K	5,900	US
208	KYTXKyverna Therapeutics, Inc. Common Stock	Equity	0.01%	$14K	2,376	US
209	OBIOOrchestra BioMed Holdings, Inc. Ordinary Shares	Equity	0.01%	$13K	2,309	US
210	ENTAEnanta Pharmaceuticals, Inc	Equity	0.01%	$13K	1,119	US
211	AVIRAtea Pharmaceuticals, Inc. Common Stock	Equity	0.01%	$13K	3,081	US
212	AUTLAutolus Therapeutics plc American Depositary Share	Equity	0.01%	$12K	7,706	GB
213	ARCTArcturus Therapeutics Holdings Inc. Common Stock	Equity	0.01%	$12K	1,092	US
214	TKNOAlpha Teknova, Inc. Common Stock	Equity	0.01%	$12K	2,062	US
215	FULCFulcrum Therapeutics, Inc. Common Stock	Equity	0.01%	$11K	2,931	US
216	CTNMContineum Therapeutics, Inc. Class A Common Stock	Equity	0.01%	$11K	1,266	US
217	CABACabaletta Bio, Inc. Common Stock	Equity	0.01%	$10K	6,513	US
218	BIOABioAge Labs, Inc. Common Stock	Equity	0.01%	$10K	1,763	US
219	LRMRLarimar Therapeutics, Inc. Common Stock	Equity	0.01%	$10K	3,991	US
220	ACIUAC Immune SA	Equity	0.01%	$10K	3,910	CH
221	LXEOLexeo Therapeutics, Inc. Common Stock	Equity	0.01%	$9K	3,152	US
222	QSIQuantum-Si Incorporated Class A Common Stock	Equity	0.01%	$9K	7,643	US
223	VNDAVanda Pharmaceuticals Inc.	Equity	0.01%	$9K	2,323	US
224	IMRXImmuneering Corporation Class A Common Stock	Equity	0.01%	$9K	2,485	US
225	RCKTRocket Pharmaceuticals, Inc. Common Stock	Equity	0.01%	$9K	4,217	US
226	LFCRLifecore Biomedical, Inc. Common Stock	Equity	0.01%	$9K	1,454	US
227	LYELLyell Immunopharma, Inc. Common Stock	Equity	0.01%	$9K	941	US
228	SIGASIGA Technologies Inc.	Equity	0.01%	$9K	2,760	US
229	KROSKeros Therapeutics, Inc. Common Stock	Equity	0.01%	$9K	762	US
230	IVVDInvivyd, Inc. Common Stock	Equity	0.01%	$7K	11,323	US
231	PEPGPepGen Inc. Common Stock	Equity	0.01%	$7K	2,661	US
232	TRDAEntrada Therapeutics, Inc. Common Stock	Equity	0.01%	$7K	1,496	US
233	SIONSionna Therapeutics, Inc. Common Stock	Equity	0.01%	$7K	1,737	US
234	BCYCBicycle Therapeutics plc American Depositary Shares	Equity	0.01%	$6K	1,795	GB
235	CHRSCoherus Oncology, Inc. Common Stock	Equity	0.01%	$6K	5,935	US
236	NBPNovaBridge Biosciences American Depositary Shares	Equity	0.01%	$6K	4,312	CN
237	UPBUpstream Bio, Inc. Common Stock	Equity	0.01%	$6K	2,104	US
238	PYXSPyxis Oncology, Inc. Common Stock	Equity	0.01%	$6K	3,204	US
239	MENSJyong Biotech Ltd. Ordinary Shares	Equity	0.01%	$6K	2,921	TW
240	CDXSCodexis, Inc.	Equity	0.01%	$5K	4,207	US
241	AVXLAnavex Life Sciences	Equity	0.01%	$5K	3,561	US
242	VYGRVoyager Therapeutics, Inc. Common Stock	Equity	0.00%	$5K	2,367	US
243	FHTXFoghorn Therapeutics Inc. Common Stock	Equity	0.00%	$5K	2,281	US
244	BDTXBlack Diamond Therapeutics, Inc. Common Stock	Equity	0.00%	$5K	2,207	US
245	HUMAHumacyte, Inc. Common Stock	Equity	0.00%	$4K	10,672	US
246	LENZLENZ Therapeutics, Inc. Common Stock	Equity	0.00%	$4K	1,207	US
247	AARDAardvark Therapeutics, Inc. Common Stock	Equity	0.00%	$4K	841	US
248	TNYATenaya Therapeutics, Inc. Common Stock	Equity	0.00%	$3K	8,614	US
249	NMRANeumora Therapeutics, Inc. Common Stock	Equity	0.00%	$3K	7,218	US
250	RANIRani Therapeutics Holdings, Inc. Class A Common Stock	Equity	0.00%	$3K	4,434
251	GOSSGossamer Bio, Inc. Common Stock	Equity	0.00%	$2K	235	US
252	CRBUCaribou Biosciences, Inc. Common Stock	Equity	0.00%	$2K	4,118	US
253	EYPTEyePoint, Inc. Common Stock	Equity	0.00%	$1K	3,312	US
254	CARTESIAN THERAPEUTICS-CVR	Equity	0.00%	$0	9,785
255	COHERUS ONCOLOGY INC COMMON STOCK USD	Equity	0.00%	$0	5,356
256	THRDThird Harmonic Bio, Inc. Common Stock	Equity	0.00%	$0	1,662	US

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
Decrease	GILDGilead Sciences, Inc.	6.48%	4.66%	−20.3%	Feb 28, 2026 → May 31, 2026 SEC
Decrease	AMGNAmgen, Inc.	6.15%	4.48%	−16.0%	Feb 28, 2026 → May 31, 2026 SEC
Decrease	VRTXVertex Pharmaceuticals, Inc.	6.27%	4.65%	−17.7%	Feb 28, 2026 → May 31, 2026 SEC
Exit	ASNDAscendis Pharma A/S	0.72%	—	—	Feb 28, 2026 → May 31, 2026 SEC
New position	Ascendis Pharma A/S	—	0.69%	—	Feb 28, 2026 → May 31, 2026 SEC
Exit	ACLXArcellx, Inc.	0.33%	—	—	Feb 28, 2026 → May 31, 2026 SEC
Exit	FOLDAmicus Therapeutics, Inc.	0.22%	—	—	Feb 28, 2026 → May 31, 2026 SEC
Exit	TERNTerns Pharmaceuticals, Inc.	0.19%	—	—	Feb 28, 2026 → May 31, 2026 SEC
Exit	APLSApellis Pharmaceuticals, Inc.	0.13%	—	—	Feb 28, 2026 → May 31, 2026 SEC
Increase	CNTACentessa Pharmaceuticals plc	0.13%	0.24%	+23.6%	Feb 28, 2026 → May 31, 2026 SEC
Increase	IMVTImmunovant, Inc.	0.24%	0.34%	+15.8%	Feb 28, 2026 → May 31, 2026 SEC
Exit	RAPTRAPT Therapeutics, Inc.	0.08%	—	—	Feb 28, 2026 → May 31, 2026 SEC
Increase	MIRMMirum Pharmaceuticals, Inc.	0.24%	0.31%	+17.1%	Feb 28, 2026 → May 31, 2026 SEC
Increase	PRAXPraxis Precision Medicines, Inc.	0.42%	0.49%	+10.9%	Feb 28, 2026 → May 31, 2026 SEC
Increase	GPCRStructure Therapeutics, Inc.	0.21%	0.15%	+16.2%	Feb 28, 2026 → May 31, 2026 SEC
Increase	WaVe Life Sciences Ltd.	0.12%	0.06%	+12.2%	Feb 28, 2026 → May 31, 2026 SEC
Exit	DAWNDay One Biopharmaceuticals, Inc.	0.05%	—	—	Feb 28, 2026 → May 31, 2026 SEC
Exit	VTYXVentyx Biosciences, Inc.	0.05%	—	—	Feb 28, 2026 → May 31, 2026 SEC
Increase	DYNDyne Therapeutics, Inc.	0.11%	0.16%	+14.9%	Feb 28, 2026 → May 31, 2026 SEC
Increase	KODKodiak Sciences, Inc.	0.07%	0.11%	+14.6%	Feb 28, 2026 → May 31, 2026 SEC
Increase	BCAXBicara Therapeutics, Inc.	0.05%	0.07%	+15.3%	Feb 28, 2026 → May 31, 2026 SEC
New position	TRAXFirst Tracks Biotherapeutics, Inc.	—	0.02%	—	Feb 28, 2026 → May 31, 2026 SEC
Increase	BCRXBioCryst Pharmaceuticals, Inc.	0.09%	0.11%	+18.8%	Feb 28, 2026 → May 31, 2026 SEC
Increase	PSNLPersonalis, Inc.	0.04%	0.06%	+17.5%	Feb 28, 2026 → May 31, 2026 SEC
Increase	VORVor BioPharma, Inc.	0.01%	0.03%	+145.9%	Feb 28, 2026 → May 31, 2026 SEC
Increase	CRVSCorvus Pharmaceuticals, Inc.	0.07%	0.05%	+10.3%	Feb 28, 2026 → May 31, 2026 SEC
Increase	GLUEMonte Rosa Therapeutics, Inc.	0.06%	0.08%	+16.7%	Feb 28, 2026 → May 31, 2026 SEC
Increase	CADLCandel Therapeutics, Inc.	0.01%	0.03%	+33.0%	Feb 28, 2026 → May 31, 2026 SEC
Increase	BNTXBioNTech SE	0.56%	0.55%	+12.4%	Feb 28, 2026 → May 31, 2026 SEC
Increase	ACRSAclaris Therapeutics, Inc.	0.02%	0.03%	+11.0%	Feb 28, 2026 → May 31, 2026 SEC
Increase	VIRVir Biotechnology, Inc.	0.06%	0.08%	+12.6%	Feb 28, 2026 → May 31, 2026 SEC
Increase	CRNXCrinetics Pharmaceuticals, Inc.	0.20%	0.19%	+10.0%	Feb 28, 2026 → May 31, 2026 SEC
Increase	ALMSAlumis, Inc.	0.15%	0.14%	+29.7%	Feb 28, 2026 → May 31, 2026 SEC
Decrease	ZLABZai Lab Ltd.	0.04%	0.03%	−12.6%	Feb 28, 2026 → May 31, 2026 SEC
Increase	PHATPhathom Pharmaceuticals, Inc.	0.04%	0.04%	+10.4%	Feb 28, 2026 → May 31, 2026 SEC
Increase	KYTXKyverna Therapeutics, Inc.	0.02%	0.02%	+30.0%	Feb 28, 2026 → May 31, 2026 SEC
Increase	VERAVera Therapeutics, Inc.	0.13%	0.13%	+11.3%	Feb 28, 2026 → May 31, 2026 SEC
Increase	LRMRLarimar Therapeutics, Inc.	0.02%	0.02%	+26.5%	Feb 28, 2026 → May 31, 2026 SEC
Increase	ALTAltimmune, Inc.	0.02%	0.02%	+19.7%	Feb 28, 2026 → May 31, 2026 SEC
Increase	CTNMContineum Therapeutics, Inc.	0.02%	0.02%	+31.2%	Feb 28, 2026 → May 31, 2026 SEC
Increase	KYMRKymera Therapeutics, Inc.	0.33%	0.33%	+13.1%	Feb 28, 2026 → May 31, 2026 SEC
Increase	BIOABioAge Labs, Inc.	0.04%	0.04%	+20.6%	Feb 28, 2026 → May 31, 2026 SEC
Decrease	FDMT4D Molecular Therapeutics, Inc.	0.03%	0.03%	−11.0%	Feb 28, 2026 → May 31, 2026 SEC
Increase	FULCFulcrum Therapeutics, Inc.	0.02%	0.02%	+22.8%	Feb 28, 2026 → May 31, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.